On Jul 7, 2021 Adial Pharmaceuticals closed a private placement of 700,001 shares of common stock and raised $5,000,000 from Bespoke Growth Partners, Keystone Capital […]
Post-IPO Equity – Spero Therapeutics
On Jun 30, 2021 Spero Therapeutics (Nasdaq: SPRO) announced $40 Million Equity Investment from Pfizer Inc. as part of the Pfizer Breakthrough Growth Initiative, a […]
Post-IPO Equity – Intellia Therapeutics
On Jun 30, 2021 Intellia Therapeutics (NTLA) announced a public offering of nearly 4.14 million shares and gained $600,000,000 by 2nd July, 2021. About the […]
